[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562778":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":17,"locations":27,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":67,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"HIV-1 infected men or women >18 years controlled in the day care center of Chokwé Hospital",null,[12],"Other: Not applicable- observational study",[14],{"type":6,"name":15,"description":15,"armGroupLabels":16,"otherNames":10},"Not applicable- observational study",[9],[18,23],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Daniel Podzamczer, PhD","CONTACT","0034675335888","dpodzamczer@gmail.com",{"name":24,"role":20,"phone":25,"phoneExt":10,"email":26},"Antonio Navarro, MSc","+0034675335888","anavarro@igtp.cat",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Hospital Carmelo","RECRUITING","Chokwé","F2C3+JPR","Mozambique","MZ",{"type":36,"coordinates":37},"Point",[38,39],32.98333,-24.53333,{"lat":39,"lon":38},[42],{"name":43,"role":20,"phone":44,"phoneExt":10,"email":45},"Elsa Jordao, MD","+2587190700","elsazith@gmail.com",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100562778","selection-of-resistant-mutations-to-dolutegravir-in-plwh-treated-in-mozambique-100562778",false,"NCT06607588","Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique","Selection of Resistant Mutations to Dolutegravir and Associated Drugs in PLWH Treated in Clinical Practice in Chokwé, Mozambique","REDOCH","Inclusion Criteria:\n\n* Patients able to understand and sign the informed consent form.\n* Documented HIV-1 infection.\n* Under the first line TLD for at least 6 months.\n* At least 3 months follow-up with CV \\>200c\u002Fml.\n\nExclusion Criteria:\n\n* Patients \\<18 years of age.\n* Under the first line regime other than TLD.\n* Patients with active neoplastic processes.\n* Patients with active opportunistic diseases.\n* Patients unable to give informed consent.","ALL","18 Years",{"count":59,"type":60},200,"ESTIMATED","1 Day","OBSERVATIONAL","The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.",[65,66],"HIV","HIV Antiretroviral Therapy (ART) Adherence",[65,68,69,70,71],"ARV","Resistance","DTG","Africa","2025-05-14",{"date":74,"type":75},"2025-05-15","ACTUAL",{"date":77,"type":75},"2024-10-25",{"date":79,"type":60},"2026-09",{"name":5,"class":6},1]